Trial · NCT01475955
Outcomes70
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 70
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Complete Clearance Rate | Week 12 | Intent to Treat (ITT) with last observation carried forward (LOCF) to impute missing data | participants | NUMBER |
| SECONDARY | Complete Clearance Rate | Week 4 | ITT LOCF | participants | NUMBER |
| SECONDARY | Complete Clearance Rate | Week 8 | participants | NUMBER | |
| SECONDARY | Complete Clearance Rate | Week 24 | participants | NUMBER | |
| SECONDARY | Partial Clearance Rate | Baseline, Week 4 | participants | NUMBER | |
| SECONDARY | Partial Clearance Rate | Baseline, Week 8 | participants | NUMBER | |
| SECONDARY | Partial Clearance Rate | Baseline, Week 12 | participants | NUMBER | |
| SECONDARY | Partial Clearance Rate | Baseline Week 24 | participants | NUMBER | |
| SECONDARY | AK Clearance Rate | Baseline, Week 4 | percent clearance | MEDIAN | |
| SECONDARY | AK Clearance Rate | Baseline, Week 8 | percent clearance | MEDIAN | |
| SECONDARY | AK Clearance Rate | Baseline, Week 12 | percent clearance | MEDIAN | |
| SECONDARY | AK Clearance Rate | Baseline, Week 24 | percent clearance | MEDIAN | |
| SECONDARY | Subject Satisfaction Score | Week 24 | participants | NUMBER | |
| SECONDARY | Hyperpigmentation at Baseline | Baseline | participants | NUMBER | |
| SECONDARY | Hyperpigmentation at Visit 2 | 24-48 Hours after PDT #1 | participants | NUMBER | |
| SECONDARY | Hyperpigmentation at Visit 3 | Week 2 | participants | NUMBER | |
| SECONDARY | Hyperpigmentation at Visit 4 | Week 4 | Number of participants analyzed reflects ITT analysis of Tolerability Data, with no imputation techniques for missing data. | participants | NUMBER |
| SECONDARY | Hyperpigmentation at Visit 5 | Week 8 | Number of participants analyzed reflects ITT analysis of Tolerability Data, with no imputation techniques for missing data. | participants | NUMBER |
| SECONDARY | Hyperpigmentation at Visit 6 | Week 12 | Number of participants analyzed reflects ITT analysis of Tolerability Data, with no imputation techniques for missing data. | participants | NUMBER |
| SECONDARY | Hyperpigmentation at Visit 7 | Week 24 | Number of participants analyzed reflects ITT analysis of Tolerability Data, with no imputation techniques for missing data. | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01475955/outcomes